The efficacy and safety of anti-Aβ agents for delaying cognitive decline in Alzheimer’s disease: a meta-analysis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The efficacy and safety of anti-Aβ agents for delaying cognitive decline in Alzheimer’s disease: a meta-analysis
Authors
Keywords
-
Journal
Frontiers in Aging Neuroscience
Volume 15, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2023-11-06
DOI
10.3389/fnagi.2023.1257973
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lecanemab Gains FDA Approval for Early Alzheimer Disease
- (2023) Howard D. Larkin JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lecanemab slows Alzheimer's disease: hope and challenges
- (2023) Simon Mead et al. LANCET NEUROLOGY
- Lecanemab: First Approval
- (2023) Sheridan M. Hoy DRUGS
- Anti-Amyloid Immunotherapies for Alzheimer’s Disease: A 2023 Clinical Update
- (2023) Golnaz Yadollahikhales et al. Neurotherapeutics
- The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics
- (2022) Eric Karran et al. NATURE REVIEWS DRUG DISCOVERY
- Safety and Efficacy of Monoclonal Antibodies for Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials
- (2022) Eleonora Lacorte et al. JOURNAL OF ALZHEIMERS DISEASE
- Therapeutic Approach to Alzheimer’s Disease: Current Treatments and New Perspectives
- (2022) Teresa Pardo-Moreno et al. Pharmaceutics
- Effects of monoclonal antibodies against amyloid-β on clinical and biomarker outcomes and adverse event risks: A systematic review and meta-analysis of phase III RCTs in Alzheimer’s disease
- (2021) Konstantinos I. Avgerinos et al. AGEING RESEARCH REVIEWS
- The Burden of Alzheimer’s Disease Mortality in the United States, 1999-2018
- (2021) Xuan Zhao et al. JOURNAL OF ALZHEIMERS DISEASE
- Prescribing Aducanumab in the Face of Meager Efficacy and Real Risks
- (2021) David S. Knopman et al. NEUROLOGY
- Revisiting FDA Approval of Aducanumab
- (2021) G. Caleb Alexander et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-Aβ agents for mild to moderate Alzheimer's disease: systematic review and meta-analysis
- (2020) Liming Lu et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Structural basis of γ-secretase inhibition and modulation by small molecule drugs
- (2020) Guanghui Yang et al. CELL
- A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease
- (2019) Francesco Panza et al. Nature Reviews Neurology
- Intravenous immunoglobulins for Alzheimer’s disease and mild cognitive impairment due to Alzheimer’s disease: A systematic review with meta-analysis
- (2019) Jia Liu et al. Expert Review of Neurotherapeutics
- BACE1 inhibitors: Current status and future directions in treating Alzheimer's disease
- (2019) Nour M. Moussa‐Pacha et al. MEDICINAL RESEARCH REVIEWS
- Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
- (2019) Justin M. Long et al. CELL
- Amyloid-β-independent regulators of tau pathology in Alzheimer disease
- (2019) Rik van der Kant et al. NATURE REVIEWS NEUROSCIENCE
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease
- (2018) Michael F. Egan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease
- (2018) Fuyuki Kametani et al. Frontiers in Neuroscience
- Clinical significance of plasma D-dimer and fibrinogen in digestive cancer: A systematic review and meta-analysis
- (2018) Yan Lin et al. EJSO
- Tau impairs neural circuits, dominating amyloid-β effects, in Alzheimer models in vivo
- (2018) Marc Aurel Busche et al. NATURE NEUROSCIENCE
- Recent Progress in Alzheimer’s Disease Research, Part 3: Diagnosis and Treatment
- (2017) Francis T. Hane et al. JOURNAL OF ALZHEIMERS DISEASE
- β-Amyloid and the Pathomechanisms of Alzheimer’s Disease: A Comprehensive View
- (2017) Botond Penke et al. MOLECULES
- Amyloid-β plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation
- (2017) Zhuohao He et al. NATURE MEDICINE
- Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy
- (2017) Sarah L. DeVos et al. Science Translational Medicine
- Efficacy and safety of anti-amyloid-β immunotherapy for Alzheimer's disease: a systematic review and network meta-analysis
- (2017) Jia-Jie Mo et al. Annals of Clinical and Translational Neurology
- Safety and Efficacy of Anti-Amyloid-β Immunotherapy in Alzheimer’s Disease: A Systematic Review and Meta-Analysis
- (2016) Ross Penninkilampi et al. Journal of Neuroimmune Pharmacology
- Failed Alzheimer’s trial does not kill leading theory of disease
- (2016) Alison Abbott et al. NATURE
- Notch signalling in context
- (2016) Sarah J. Bray NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Amyloid-ß-directed immunotherapy for Alzheimer's disease
- (2014) L. Lannfelt et al. JOURNAL OF INTERNAL MEDICINE
- The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials
- (2014) Reisa Sperling et al. NEURON
- Development and Mechanism of γ-Secretase Modulators for Alzheimer’s Disease
- (2013) Christina J. Crump et al. BIOCHEMISTRY
- Trafficking and Proteolytic Processing of APP
- (2013) C. Haass et al. Cold Spring Harbor Perspectives in Medicine
- Differential Effects between -Secretase Inhibitors and Modulators on Cognitive Function in Amyloid Precursor Protein-Transgenic and Nontransgenic Mice
- (2012) Y. Mitani et al. JOURNAL OF NEUROSCIENCE
- Review: Cochrane handbook for systematic reviews for interventions, Version 5.1.0, published 3/2011. Julian P.T. Higgins and Sally Green, Editors
- (2011) Jonathan J. Shuster Research Synthesis Methods
- REVIEW: γ-Secretase Inhibitors for the Treatment of Alzheimer's Disease: The Current State
- (2010) Francesco Panza et al. CNS Neuroscience & Therapeutics
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search